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Summary
Background. Opioid overdose is the primary cause of death among injecting drug users (IDU). Overdose is generally 
not sudden, occurs over one to three hours, and often in the presence of bystanders. This presents a unique window of 
opportunity to intervene. Aim. Successful overdose prevention training includes appropriate clinical and non-clinical re-
sponses. The study aimed to investigate Irish IDU experience of overdose, and need for education and resuscitation skills 
programming. We report on pilot indings. Methods. Phase One assessed service user experience of overdose, substances 
used, setting for overdose, and awareness of appropriate non-clinical responses (n=52). Phase two implemented an edu-
cational intervention at two Cork addiction service sites. This involved assessing service user awareness of appropriate 
non-clinical methods to manage overdose and their interest in receiving resuscitation training (n=26). Phase three piloted 
a resuscitation skills training intervention for staff, family and IDU consisting of instruction on how to recognise and 
prevent overdose, appropriate response techniques; rescue breathing, and calling emergency services (n=26). Results. 
The indings illustrated the majority had experienced overdose, described the main substances involved, the settings, the 
responses employed, and the perceptions of risk. The need for education equipping IDU with overdose prevention and 
management skills was identiied. Awareness of appropriate responses (correct emergency numbers, recovery and resus-
citation skills) improved following the educational and skills training interventions. Conclusions. Continued efforts in 
Ireland to integrate culturally speciic overdose prevention into agonist opioid treatment services, prison discharge, home-
less primary health and needle and syringe exchange are warranted. 
Key Words: Overdose prevention; cardio pulmonary resuscitation training; injecting drug user
1. Introduction
Opioid overdose is the primary cause of death 
among injecting drug users (IDU) [34; 42] with over 
half of IDU reporting at least one non-fatal overdose 
experience in their lifetime [36]. Drug related deaths 
otherwise known as overdoses or poisonings occur as 
therapeutic misadventures or adverse consequences 
from licit use of pain management or opioid main-
tenance medication, or from non-medical use of pre-
scription opioids or illicit opiates such as heroin [33, 
45]. In relation to illicit drug use, a number of risk 
factors for overdose are identiied which include age 
and gender, administration by injection as opposed 
to smoking or snorting of heroin, drug purity and 
availability, miscalculations in assessing strength of 
drugs prior to use, low tolerance in sporadic users, 
sharing of syringes and drug injecting paraphernalia, 
concurrent and sequential polydrug use and injecting 
use of other substances with opioids such as alcohol, 
cocaine, methamphetamines, benzodiazepines and 
barbiturates, experience of serious withdrawals in 
the past two months, HIV + status, participation in 
methadone maintenance treatment, recent incarcera-
tion, participation in sex work, presence of co-morbid 
disorder, lack of permanent housing and discharge 
from prison [1, 6, 8, 11, 16, 17, 20, 28, 32, 34, 41]. 
Substance users with a history of suicide intent or 
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previous attempts at self-harm are at increased risk 
of reporting intentional and unintentional overdose 
[3], sometimes catalysed by personal situation, real 
life problems, poor coping mechanisms and traumat-
ic events [29, 30]. The presence of systemic disease 
resulting in pulmonary or hepatic dysfunction addi-
tionally increases vulnerability to fatal and non-fatal 
overdoses [44]. Protective factors relate to presence 
of social supports, structured drug treatment pro-
grammes, community and family [1, 41]. 
Experience of overdose is itself a risk factor, with 
potential for overdose increasing for each overdose 
reported [8, 31]. Studies have described IDU lack of 
perceived personal risk of overdose, despite recogni-
tion of peer risk [10, 27]. Optimism around potential 
future overdose is reported in heroin users with recent 
experience of overdose [27]. Of note however is that 
cumulative risk of overdose increases as frequency of 
injecting use of heroin increases [6]. Experience of 
overdose and the witnessing of someone else’s over-
dose is common among injecting drug users [31]. 
Through fear of incarceration, witnesses may, when 
witnessing an overdose, run rather than call for help 
[23]. Overdosing is generally not a solitary experi-
ence [31] with the majority of nonfatal overdoses 
occurring in the company of others. Characteristics 
of drug users who witness overdoses include being 
male, with experience of homelessness, prior use of 
heroin, personal experience of overdose and attend-
ance at Narcotics Anonymous [4]. These individuals 
were reportedly less likely to seek medical assistance 
and more likely report counterproductive or useless 
actions at the last overdose they witnessed, in com-
parison with drug users who only witness one or two 
overdoses. Bohnert et al., [4] underscore that these 
individuals and groups of IDU are key targets of over-
dose response training. Other studies point to the need 
to target large drug networks for overdose prevention 
interventions [23, 24]. 
As overdose is generally not sudden [36], occurs 
over the course of one to three hours, and often in the 
presence of another drug users, this presents a unique 
window of opportunity to intervene with life saving 
measures by bystander response. Successful overdose 
prevention training includes the training in how to 
reduce overdose risk, recognise overdose, stimulate 
the victim (i.e. sternum rub), administer naloxone by 
intramuscular injection or nasal spraying of the injec-
tion prior to the arrival of paramedics, rescue breath-
ing and calling of emergency numbers [7, 38, 23, 45]. 
Naloxone (THN) is an antidote to opioid overdose 
[5, 16; 45]. Effectiveness of naloxone components in 
overdose prevention programmes is well evidenced 
[25, 40]. Strang et al., [39] reported on how fellow 
drug users on average report three different actions 
on witnessing a peer overdose, and express interest 
in learning and expanding their skills in overdose 
interventions (particularly cardio-pulmonary resus-
citation techniques and administration of naloxone). 
Studies have described barriers to calling emergency 
numbers, fear of police involvement [22], and how 
participation in overdose prevention training pro-
grammes assist dialogue among IDUs on the subject 
of overdose [38]. Barriers which prevent IDUs from 
acting in the recommended manner include prior suc-
cess by administering folk remedies in reviving the 
victim, fear of police, and issues impacting on access 
to and use of naloxone [23]. 
In Ireland, in the period 2004-2012, 5,289 deaths 
by drug poisoning and deaths among drug users were 
recorded, of which 3,112 were due to poisoning, and 
2,177 deaths among drug users (non-poisoning). Of 
concern is that deaths due to polydrug use increased 
by 60% in this reporting period [18]. An Irish study 
has previously illustrated that overdose prevention 
and management of overdose is a key issue for gen-
eral practitioners caring for opiate dependent patients 
[9]. Naloxone is however currently not available to 
IDUs in Ireland. The study aimed to investigate Irish 
IDU experience of fatal/non-fatal/accidental/inten-
tional overdose, and the need for appropriate educa-
tion and resuscitation skills programming. We report 
here on preliminary pilot indings. 
2. Methods
Overdose prevention programmes generally in-
clude information on how to avoid an opioid over-
dose and how bystanders should respond safely if an 
overdose is witnessed by safely stimulating the vic-
tim, calling of emergency medical services, rescue 
breathing and administration of naloxone (if licensed 
in that country) [43]. Whilst overdose prevention pro-
grammes are unique and for a unique target group, 
they share similarities with cardio-pulmonary resus-
citation training (CPR) provided to bystanders who 
may witness a person in cardiac arrest. 
The study setting was two addiction treatment 
services in Cork, the second largest city in the Re-
public of Ireland. Recent treatment data record in 
2012 there were 49 cases who entered methadone 
treatment. In addition, on the 1st January 2012, 87 
additional cases continued in methadone treatment 
from previous years. This gives a total of 136 cases 
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in methadone treatment in 2012. Some of these cases 
may have returned to treatment two or more times 
within the calendar year. See Table 1. 
The study was operated as part of internal audit 
of service users and as per Health Service Executive 
protocols. It contained three components. Phase One 
aimed to explore service user personal experience 
of fatal/non-fatal/accidental/intentional overdose, 
awareness of appropriate responses to an overdose 
scenario and identify if there was a need for resusci-
tation skills education. A brief survey was compiled 
based on consultation with the literature and dis-
cussions between investigators (AH, CD, KH). The 
survey investigated the patient’s lifetime and recent 
(past six month) personal experiences of non-fatal ac-
cidental and/or intentional overdoses, the substances 
involved, risk perceptions and concern for personal 
and peer overdose, frequency of witnessing of a peer 
fatal or non-fatal overdose, site where the witnessed 
fatal or non-fatal overdose took place, presence of 
other people, if an ambulance was called and using 
what number, awareness of appropriate non clinical 
methods to manage the overdose (recovery position, 
basic resuscitation) and interest in overdose preven-
tion training (n=52). 
Phase Two implemented an educational inter-
vention at the two addiction service sites. This inter-
vention consisted of a DVD “Overdose, Four short 
ilms about the prevention of overdose death” by 
Harm Reduction Works in the UK, which was de-
signed to focus the viewer on the realities and dangers 
relating to overdose, and how to respond appropri-
ately. The ilm was played in the waiting areas for 4 
weeks. Phase Two re-audited with 26 service users 
who took part in Phase One, and surveyed awareness 
of appropriate non-clinical methods to manage over-
dose (recognition of correct emergency number and 
recovery positions). Clients were asked if they would 
avail of further training in cardio-pulmonary resusci-
tation skills. 
Phase Three comprised of a resuscitation skills 
training pilot in 2013 which was conducted in col-
laboration with a consultant of emergency medicine 
(CD) and an advanced paramedic (KH). This Resus-
citation Skills Training Pilot was directed at both ser-
vice users, and staff. This intervention consisted of 
instruction on how to recognise and prevent overdose, 
appropriate response techniques; rescue breathing, 
and for and appropriately facilitating an emergency 
service response. It involved recruitment of drug user 
participants from three sources; invitation of Phase 
Two participants (n=4), a Community Brief Interven-
tion group consisting of staff (n=2) and more chaotic 
drug users (n=4), and an Addiction training course for 
staff and family members (n=10) and stabilised ex-
users (n=6). Discussions also took place around par-
ticipant perceptions of high risk behaviours. Service 
users were taken through real life scenarios, provided 
with instructions on how to reduce the risk of over-
dose and the actions that should occur following an 
overdose. These include what to expect when calling 
for an Ambulance, how to facilitate the Emergency 
Response, the importance of staying with the victim, 
reassurance that law enforcement would appreciate 
their help in saving a life etc. Training consisted of 
a didactic instructional component, hands-on using 
mannequins and engaging in role-play to practice the 
recovery positions, chest compressions and response 
techniques. Following the event a debrief focus group 
discussion was undertaken. A certiicate of attendance 
was provided to add to the status and positive feelings 
that participants would have about the course. Partici-
pants also completed a brief evaluation questionnaire 
asking two questions relating to perceived beneit and 
recommendation to a friend, and open questions as to 
how the intervention could be improved, and if par-
ticipants would like to be involved in the design and 
development of an Irish training DVD. 
The data was collected in an ethical and coni-
dential manner, by virtue of informed consent prior to 
participation, the ability to withdraw from the study 
if requested, anonymity of participants by virtue of 
coding, and provision of overdose information should 
participants be at risk of harm. The data was analysed 
using SPSS to provide description and content related 
information. 
Table 1 Age and gender of all cases in methadone treatment
Gender N Median Mean Std. Deviation Range
Male 96 30.0 31.2 6.9 18 to 51
Female 40 27.0 28.2 6.7 18 to 49
Total 136 29.0 30.3 6.9 18 to 51
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3. Results
3.1. Phase One survey
52 service users completed Phase One survey 
with mean age 30 years, of which 12 were female and 
40 were male. Due to the small sample size and lack 
of gender balance we did not engage in further cross 
tabulated gender analysis. 
3.2. Personal experience of overdose
59.6% had experienced overdose in their lives, 
and with 9.6% reporting an overdose in the previous 
6 months. This amounted to 77 overdose incidents, 
or 2.65 incidents per individual. Of those, 80% were 
accidental, but 20% were intentional. 
3.3. Substances involved in overdose
Heroin was the substance most represented in 
terms of total experience of overdose (60.0%), and 
most implicated in accidental overdoses (66.67%). 
For those reporting experience of intentional over-
dose, benzodiazepines were most reported (83.33%). 
See Table 2.
Other substances (30%) were reported, and in-
cluded MDMA and paracetamol in the intentional 
category (50%), and codeine, amphetamine, DF118, 
MDMA, tramadol, paracetamol and distalgesics in 
the accidental overdose category (25%). 
3.4. Witnessed overdose
55.77% reported witnessing a non-fatal over-
dose, and 19.23% reported witnessing a fatal over-
dose. The total overdose incidents came to 121, of 
these 97 were non-fatal (3.3 average), and 24 fatal 
(2.4 average). Of those who reported personal experi-
ence of accidental overdose, 70.83% had witnessed a 
non-fatal overdose themselves, and 29.17% had wit-
nessed a fatal overdose. For those who had never ex-
perienced an overdose, 47.62% reported witnessing a 
non-fatal overdose, and 9.52% reported witnessing a 
fatal overdose. 
3.5. Concern around overdose
53.84% reported never or rarely worrying about 
overdosing. 50.0% of those who reported accidental 
overdose never/rarely worried about personal over-
dose, compared with 62.90% of those who never ex-
perienced an overdose. See Table 3.
But when asked what percentage of substance 
users, participants thought would overdose in their 
lifetime, 75% indicated that half or more would over-
Table 2: Substances involved in overdose
Substance Intentional Overdose Accidental Overdose Total Overdose
Heroin 33.3% 66.6% 60.0%
Methadone 0.0% 20.8% 16.6%
Cocaine 0.0% 8.3% 6.6%
Alcohol 33.3% 33.3% 33.3%
Cannabis 16.6% 12.5% 13.3%
Benzodiazepines 83.3% 37.5% 46.6%
Novel Psychoactives 0.0% 8.3% 6.6%
Other Substances 50.0% 25.0% 30.0%
Table 3 Concern around overdose
Overall
Experienced 
Accidental OD
Never Expe-
rienced OD
Worry about Overdose
Never 32.6% 20.8% 47.6%
Rarely 21.1% 29.1% 14.2%
Sometimes 32.6% 33.3% 33.3%
Fairly Often 11.5% 16.6% 4.7%
Most of the time 1.9% 0.0% 0.0%
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73% knew what the recovery position was, and when 
questioned around interest in undertaking resuscita-
tion skills training, 77% indicated interest.
3.9. Phase Three: pilot resuscitation training
26 participants took part in Phase Three; invita-
tion of Phase Two participants (n=4), a Community 
Brief Intervention group consisting of staff (n=2) 
and more chaotic drug users (n=4), and an Addiction 
training course for staff and family members (n=10) 
and stabilised ex-users (n=6). 
A brief evaluation questionnaire asked two ques-
tions relating to perceived beneit and recommenda-
tion to a friend, and open questions as to how the 
intervention could be improved, and if participants 
would like to be involved in the design and develop-
ment of an Irish training DVD. 16 participants com-
pleted the open ended evaluation survey and 20 were 
involved in the focus group as part of the Addiction 
Training course. Key themes are presented in Table 5. 
4. Discussion 
Understanding IDU perceptions of risk associ-
ated with overdose, their attitudes and responses to 
overdose and their overdose prevention, risk manage-
ment and coping strategies is pivotal to developing 
effective responses to prevent overdose and overdose 
fatalities. There is a growing awareness among IDU 
of their personal capacity to reduce harm [19]. Drug 
user involvement as ‘public health ally’ or collabo-
rator in contrast to victim or patient is increasingly 
the new public image amid heightened service user 
involvement movements in drug treatment care [43]. 
As overdose is preventable, audit studies such as this 
Irish pilot in conjunction with development of proto-
cols and interventions have a key role to play in un-
derstanding the dynamics of overdose situations, and 
the regional medical and health professional devel-
opment of overdose prevention and risk management 
interventions [2, 14, 30, 32, 45]. The results in this 
pilot study in Ireland underscore the interest in and 
need for overdose prevention programmes, alongside 
increases in awareness and potential for positive so-
cial and drug taking behaviour change of IDU and 
through the process of assuming new responsible so-
cial roles as overdose responders (see Wagner et al., 
[43]). Participant views around risk perceptions are 
similar to studies elsewhere [10]. Findings further 
highlight the need for Irish policy makers to consid-
er expansion to provide intranasal naloxone to sub-
dose. 83% of those with experience of accidental 
overdose reported that half or more of substance us-
ers would likely overdose in their lifetime compared 
with 62% of those with no experience of overdose. 
See Table 4.
3.6. Overdose setting
When asked where the overdoses occurred, in 
the non-fatal subgroup, 52% were reported to have 
occurred in a private home, and 22% on the street. 
But in the fatal subgroup, 87% were reported to have 
occurred in a private home. Of those that reported 
witnessing an overdose; 80% reported that other peo-
ple were present, 80% reported calling an ambulance, 
and 55% reported placing the person in a recovery 
position on their side.
3.7. Awareness of appropriate non-clinical methods 
of managing an overdose 
When asked what number to use to call an am-
bulance, 92.31% were correct, 7.69% indicated an in-
correct response. 61.54% reported that they knew of 
the recovery position, 48.08% reported that they knew 
basic resuscitation. When questioned around further 
training needs, 65.38% reported interested in learning 
basic resuscitation skills. Those with personal experi-
ence of accidental overdose reported a higher interest 
in learning resuscitation skills (70.83%), compared 
with 61.90% of those with no experience of overdose. 
3.8. Phase Two: educational intervention survey
26 service users from the original sample of 
52 who completed Phase One survey completed the 
survey, with mean age 32 years and 5 females/21 
males. Following this 4 week educational interven-
tions, 100% reported the correct ambulance number, 
Table 4. Perception of substance users lifetime overdose 
risk
What percentage of sub-
stance users they perceived 
would overdose in their 
lifetime:
Proportion of sample
10% 7.69%
25% 17.31%
50% 30.77%
75% 34.62%
90% 9.62%
100% 0.0%
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networks can only boost the salience of outcomes 
[43]. Studies have observed how intervention partici-
pants can diffuse and share information on overdose 
prevention and use of naloxone with peers and fam-
ily [36]. Overdose prevention and response training 
programmes can additionally stimulate unforeseen 
impacts in relation to reduced personal drug use [42] 
and reduced frequency of heroin injection [35]. How-
ever concerns are evident with regard to the dissemi-
nation of overdose training from trained to untrained 
individuals, and the potential false sense of security 
garnered and potentially resulting in increased opioid 
use [13]. Limited research is conducted to date on the 
factors inhibiting or stimulating IDUs to undertake 
the recommended response techniques in the event of 
an overdose when trained [23]. 
5. Conclusion
Equipping IDU with skills and education around 
overdose prevention and management can beneit 
individual, IDU networks and communities. Con-
tinued efforts in Ireland to integration of culturally 
and learner speciic overdose prevention into agonist 
opioid treatment services, prison discharge, homeless 
services, primary health and needle and syringe ex-
change are warranted.
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